# ARrest RESpiraTory Failure From PNEUMONIA

> **NCT04193878** · PHASE3 · TERMINATED · sponsor: **Stanford University** · enrollment: 465 (actual)

## Conditions studied

- Pneumonia
- Hypoxemia
- Acute Respiratory Failure
- COVID-19 Pneumonia

## Interventions

- **DRUG:** Inhaled budesonide and formoterol
- **DRUG:** Inhaled placebo

## Key facts

- **NCT ID:** NCT04193878
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-01
- **Primary completion:** 2025-07-22
- **Final completion:** 2025-07-22
- **Target enrollment:** 465 (ACTUAL)
- **Why stopped:** Per DSMB's review of interim analysis, the study has reached the pre-specified futility criteria
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04193878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04193878, "ARrest RESpiraTory Failure From PNEUMONIA". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04193878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
